Trial intelligence / Profile preview

Propranolol for Post-Stroke Pneumonia

NCT05419193Phase 3Completed

Sponsor
Beijing Tiantan Hospital
Start
Feb 2023
Primary completion
Dec 2024
Modality
Small Molecules
Countries
1
01

Overview

A Phase 3 trial of propranolol in pneumonia, sponsored by Beijing Tiantan Hospital. Started Feb 2023; status: completed.

02

Drugs

propranolol
03

Conditions

pneumonia

Beyond the preview

Go deeper on NCT05419193.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05419193.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call